|
ATE128129T1
(de)
|
1986-07-28 |
1995-10-15 |
American Cyanamid Co |
5(und/oder6) substituierte 2-(2-imidazolin-2- yl)nicotinsäuren, ester und salze, verwendbar als herbizide mittel und zwischenverbindungen für die herstellung dieser nikotinsäuren, ester und salze.
|
|
FR2624698A1
(fr)
|
1987-12-18 |
1989-06-23 |
Bernard Lyon I Universite Clau |
Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-aminomalonyl ou aminosuccinyl amides utiles comme agents edulcorants
|
|
WO1990009787A1
(en)
|
1989-02-27 |
1990-09-07 |
The Du Pont Merck Pharmaceutical Company |
Novel sulfonamides as radiosensitizers
|
|
US5776963A
(en)
|
1989-05-19 |
1998-07-07 |
Hoechst Marion Roussel, Inc. |
3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
|
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
|
JP2807577B2
(ja)
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
|
EP0520573A1
(en)
|
1991-06-27 |
1992-12-30 |
Glaxo Inc. |
Cyclic imide derivatives
|
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5389631A
(en)
|
1991-10-29 |
1995-02-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
|
US5364869A
(en)
|
1992-03-09 |
1994-11-15 |
Abbott Laboratories |
Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
|
|
US5326760A
(en)
|
1992-06-29 |
1994-07-05 |
Glaxo, Inc. |
Aminobutanoic acid compounds having metalloprotease inhibiting properties
|
|
JPH06236056A
(ja)
|
1993-02-10 |
1994-08-23 |
Fuji Xerox Co Ltd |
電子写真感光体
|
|
JP3760474B2
(ja)
|
1993-04-22 |
2006-03-29 |
ダイキン工業株式会社 |
電気エネルギーを発生させる方法、装置およびそれに用いるｎ−ｆ結合を有する化合物
|
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
|
DE4343922A1
(de)
|
1993-12-22 |
1995-06-29 |
Basf Ag |
Pyridin-2,3-dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
|
|
KR970007419B1
(ko)
|
1993-12-30 |
1997-05-08 |
한솔제지 주식회사 |
승화형 열전사 기록용 색소
|
|
FR2725946A1
(fr)
|
1994-10-24 |
1996-04-26 |
Lohr Ind |
Cale a rapporter sur un plan porteur presentant des perforations
|
|
US5719144A
(en)
|
1995-02-22 |
1998-02-17 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5770590A
(en)
|
1995-03-24 |
1998-06-23 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their prudiction and use
|
|
NO309272B1
(no)
|
1995-03-24 |
2001-01-08 |
Takeda Chemical Industries Ltd |
Cykliske forbindelser, preparater inneholdende forbindelsene samt mellomprodukter for fremstilling av forbindelsene
|
|
WO1997024334A1
(en)
*
|
1995-12-28 |
1997-07-10 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
|
DE19608791A1
(de)
|
1996-03-07 |
1997-09-11 |
Hoechst Ag |
Verfahren zur Herstellung von fluorierten Aromaten und fluorierten stickstoffhaltigen Heteroaromaten
|
|
DE19702282C2
(de)
|
1997-01-23 |
1998-11-19 |
Hoechst Ag |
Katalysator für Halex-Reaktionen
|
|
WO1998040385A1
(en)
|
1997-03-07 |
1998-09-17 |
Novo Nordisk A/S |
4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
|
|
US6177443B1
(en)
|
1997-03-07 |
2001-01-23 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
|
|
KR19980074060A
(ko)
|
1997-03-21 |
1998-11-05 |
김윤배 |
신규한 치환된 3,4-디알콕시페닐 유도체
|
|
JPH1143489A
(ja)
|
1997-05-30 |
1999-02-16 |
Takeda Chem Ind Ltd |
ヘテロ環化合物、その製造法および剤
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
EP1184036A2
(en)
|
1998-03-19 |
2002-03-06 |
Takeda Chemical Industries, Ltd. |
Heterocyclic compounds, their production and use as tachykinin receptor antagonists
|
|
FR2778662B1
(fr)
|
1998-05-12 |
2000-06-16 |
Adir |
Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2000007661A
(ja)
|
1998-06-23 |
2000-01-11 |
Nippon Nohyaku Co Ltd |
複素環ジカルボン酸ジアミド誘導体及びその中間体並びに除草剤
|
|
US6444617B1
(en)
|
1998-07-28 |
2002-09-03 |
Nihon Nohyaku Co., Ltd. |
Fused-heterocycle dicarboxylic acid diamide derivatives or salts thereof, herbicide and usage thereof
|
|
US6348032B1
(en)
*
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
|
WO2000032192A1
(en)
|
1998-11-27 |
2000-06-08 |
Takeda Chemical Industries, Ltd. |
Drugs
|
|
AU4841700A
(en)
|
1999-05-12 |
2000-11-21 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
NZ516348A
(en)
*
|
1999-06-23 |
2003-06-30 |
Aventis Pharma Gmbh |
Substituted benzimidazole
|
|
CA2378202A1
(en)
|
1999-07-21 |
2001-01-25 |
Odd-Geir Berge |
New compounds
|
|
DE60014928T2
(de)
|
1999-08-02 |
2006-03-09 |
F. Hoffmann-La Roche Ag |
Retinoide zur behandlung von emphysem
|
|
CA2389193A1
(en)
|
1999-11-09 |
2001-05-17 |
Abbott Laboratories |
Hydromorphone compositions and methods of their synthesis
|
|
NZ514403A
(en)
|
1999-12-27 |
2002-10-25 |
Japan Tobacco Inc |
Fused-ring compounds and use thereof as drugs
|
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
WO2001051128A1
(en)
|
2000-01-12 |
2001-07-19 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
CA2377629A1
(en)
|
2000-04-25 |
2001-11-08 |
Hae-Young Bae |
Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
|
|
CA2354606C
(en)
|
2000-08-03 |
2005-12-06 |
Pfizer Products Inc. |
Azabicycloalkane derivatives and therapeutic uses thereof
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
TWI236474B
(en)
|
2001-04-03 |
2005-07-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
|
WO2002081447A1
(en)
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
|
PT1385823E
(pt)
|
2001-04-09 |
2007-01-31 |
Novartis Vaccines & Diagnostic |
Compostos de guanidino como agonistas do receptor de melanocortina-4 (r-mc4)
|
|
US7476688B2
(en)
|
2001-04-19 |
2009-01-13 |
Eisai R&D Management Co., Ltd. |
Cyclic amidine derivatives
|
|
PT1397364E
(pt)
|
2001-05-24 |
2007-10-22 |
Lilly Co Eli |
Novos derivados de pirrole como agentes farmacêuticos
|
|
WO2003008421A1
(en)
|
2001-07-16 |
2003-01-30 |
Shionogi & Co., Ltd. |
Process for preparation of amidine derivatives
|
|
WO2003029254A1
(en)
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Process for preparation of tricyclic compounds
|
|
JP2003171380A
(ja)
|
2001-09-28 |
2003-06-20 |
Takeda Chem Ind Ltd |
三環性化合物の製造法
|
|
KR100614900B1
(ko)
|
2001-10-02 |
2006-08-25 |
파마시아 앤드 업존 캄파니 엘엘씨 |
질병의 치료를 위한 아자비시클릭-치환된 융합-헤테로아릴화합물
|
|
DE10156719A1
(de)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
Heteroarylcarbonsäureamide
|
|
TWI263640B
(en)
|
2001-12-19 |
2006-10-11 |
Bristol Myers Squibb Co |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
MXPA04007502A
(es)
|
2002-02-04 |
2004-11-10 |
Hoffmann La Roche |
Derivados de quinolina como antagonistas de neuropeptido y (npy).
|
|
DE10207037A1
(de)
|
2002-02-20 |
2003-08-28 |
Bayer Cropscience Gmbh |
2-Amino-4-bicyclyamino-6H-1,3.5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2003076440A1
(en)
|
2002-03-06 |
2003-09-18 |
Smithkline Beecham Corporation |
Condensed heterocyclic compounds as calcitonin agonists
|
|
US20040077529A1
(en)
|
2002-06-10 |
2004-04-22 |
Per-Fredrik Lehmann |
Urotensin II receptor agents
|
|
WO2004014365A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Phthalimide derivatives as matrix metalloproteinase inhibitors
|
|
ES2291664T3
(es)
|
2002-09-17 |
2008-03-01 |
Eli Lilly And Company |
Derivados de pirazolopiridina como inhibidores de la transduccion de señales de tgf beta para el tratamiento del cancer.
|
|
EP2957568B1
(en)
|
2002-11-05 |
2016-12-21 |
Ionis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
|
JP2004203791A
(ja)
|
2002-12-25 |
2004-07-22 |
Dai Ichi Seiyaku Co Ltd |
芳香族化合物
|
|
CN1212674C
(zh)
|
2003-01-08 |
2005-07-27 |
东南大学 |
横向缓冲p型金属氧化物半导体管
|
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
GB0308025D0
(en)
|
2003-04-07 |
2003-05-14 |
Glaxo Group Ltd |
Compounds
|
|
PE20050158A1
(es)
|
2003-05-19 |
2005-05-12 |
Irm Llc |
Compuestos inmunosupresores y composiciones
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
BRPI0410454A
(pt)
|
2003-05-19 |
2006-06-13 |
Irm Llc |
composições e compostos imunossupressores
|
|
JP4728962B2
(ja)
|
2003-05-19 |
2011-07-20 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
免疫抑制化合物および組成物
|
|
EP1628661A2
(en)
|
2003-06-05 |
2006-03-01 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
|
CN1566099A
(zh)
|
2003-06-13 |
2005-01-19 |
中国科学院上海药物研究所 |
异喹啉－1,3,4－三酮类化合物、制备方法及其用途
|
|
EP1660454A1
(en)
|
2003-07-07 |
2006-05-31 |
Vernalis (R&D) Limited |
Azacyclic compounds as inhibitors of sensory neurone specific channels
|
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
CA2533554A1
(en)
|
2003-08-01 |
2005-02-10 |
Pfizer Products Inc. |
6-membered heteroaryl compounds for the treatment of neurodegenerative disorders
|
|
WO2005028480A2
(en)
|
2003-09-03 |
2005-03-31 |
Neurogen Corporation |
5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
|
AP2006003559A0
(en)
|
2003-09-05 |
2006-04-30 |
Neurogen Corp Ventis Pharmaceuticals Inc |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF 1 receptor ligands
|
|
WO2005025504A2
(en)
|
2003-09-12 |
2005-03-24 |
Kemia, Inc. |
Modulators of calcitonin and amylin activity
|
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
|
US7732616B2
(en)
|
2003-11-19 |
2010-06-08 |
Array Biopharma Inc. |
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
|
|
AU2004293436B2
(en)
|
2003-11-19 |
2010-12-09 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
|
CA2549638A1
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Products Inc. |
Therapeutic combination for cognition enhancement and psychotic disorders
|
|
WO2005097129A2
(en)
|
2004-04-05 |
2005-10-20 |
Takeda Pharmaceutical Company Limited |
6-azaindole compound
|
|
WO2005100334A1
(en)
|
2004-04-14 |
2005-10-27 |
Pfizer Products Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
|
KR101331786B1
(ko)
|
2004-09-22 |
2013-11-21 |
얀센 파마슈티카 엔.브이. |
Ｍｄｍ2 및 ｐ53간의 상호작용 저해제
|
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
|
KR20070115879A
(ko)
|
2005-01-07 |
2007-12-06 |
에모리 유니버시티 |
의학 장애의 치료용 ｃｘｃｒ4 길항제
|
|
ES2334578T3
(es)
|
2005-02-07 |
2010-03-12 |
F. Hoffmann-La Roche Ag |
Fenil-metanonas sustituidas por heterociclo como inhibidores del transportador 1 de la glicina.
|
|
GB0504556D0
(en)
|
2005-03-04 |
2005-04-13 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
DE102005012872A1
(de)
*
|
2005-03-19 |
2006-09-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
PL1877379T3
(pl)
|
2005-04-13 |
2013-06-28 |
Astex Therapeutics Ltd |
Pochodne hydroksybenzamidu i ich wykorzystanie, jako inhibitorów hsp90
|
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
|
WO2007007054A1
(en)
|
2005-07-08 |
2007-01-18 |
Cancer Research Technology Limited |
Phthalamides, succinimides and related compounds and their use as pharmaceuticals
|
|
EP1940819A1
(en)
|
2005-08-16 |
2008-07-09 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 10 inhibitors
|
|
EP1940836A1
(en)
|
2005-09-29 |
2008-07-09 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
|
|
US8158791B2
(en)
|
2005-11-10 |
2012-04-17 |
Msd K.K. |
Aza-substituted spiro derivatives
|
|
PE20071241A1
(es)
|
2006-01-17 |
2008-01-14 |
Schering Corp |
Compuestos derivados de hidantoina para el tratamiento de trastornos inflamatorios
|
|
WO2007084815A2
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica, N.V. |
Substituted thienopyrimidine kinase inhibitors
|
|
JP5111398B2
(ja)
|
2006-01-25 |
2013-01-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼｉｖ阻害剤としてのアミノシクロヘキサン類
|
|
WO2007097931A2
(en)
|
2006-02-15 |
2007-08-30 |
Merck & Co., Inc. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
AU2007220040A1
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods to identify inhibitors of the unfolded protein response
|
|
US7977351B2
(en)
|
2006-03-22 |
2011-07-12 |
Allergan, Inc. |
Heteroaryl dihydroindolones as kinase inhibitors
|
|
CA2644649C
(en)
|
2006-03-22 |
2014-06-17 |
Janssen Pharmaceutica N.V. |
Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
|
|
EP2023919A4
(en)
|
2006-05-08 |
2010-12-22 |
Molecular Neuroimaging Llc |
COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES
|
|
EA200802210A1
(ru)
|
2006-05-16 |
2009-06-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств
|
|
CN1869036A
(zh)
|
2006-06-30 |
2006-11-29 |
中国药科大学 |
7－取代－3－氯吡咯并[3,4－b]吡啶化合物
|
|
DE102006032824A1
(de)
|
2006-07-14 |
2008-01-17 |
Bayer Healthcare Ag |
Substituierte Indazole
|
|
US20100056516A1
(en)
|
2006-07-17 |
2010-03-04 |
Williams Peter D |
1-hydroxy naphthyridine compounds as anti-hiv agents
|
|
WO2008013963A2
(en)
|
2006-07-28 |
2008-01-31 |
University Of Connecticut |
Fatty acid amide hydrolase inhibitors
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
US8883790B2
(en)
|
2006-10-12 |
2014-11-11 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008044054A2
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Hydroxy-substituted benzoic acid amide compounds for use in therapy
|
|
EP2073803B1
(en)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8277807B2
(en)
|
2006-10-12 |
2012-10-02 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
JP5410285B2
(ja)
|
2006-10-12 |
2014-02-05 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
|
CN101600437A
(zh)
|
2006-12-11 |
2009-12-09 |
诺瓦提斯公司 |
预防或治疗心肌缺血的方法
|
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
|
WO2008086161A1
(en)
|
2007-01-08 |
2008-07-17 |
Phenomix Corporation |
Macrocyclic hepatitis c protease inhibitors
|
|
WO2009004496A2
(en)
|
2007-04-13 |
2009-01-08 |
University Of Manitoba |
Bisanthrapyrazoles as anti-cancer agents
|
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
US20100129933A1
(en)
|
2007-04-26 |
2010-05-27 |
Forschungszentrum Karlsruhe Gmbh |
Method for detecting the binding between mdm2 and the proteasome
|
|
AR066379A1
(es)
|
2007-05-02 |
2009-08-12 |
Boehringer Ingelheim Int |
Amidas de acido carboxilico su preparacion y su uso como medicamentos
|
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
|
AU2008251476B2
(en)
|
2007-05-10 |
2014-06-12 |
Plastipak Packaging, Inc. |
Oxygen scavenging molecules, articles containing same, and methods of their use
|
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
|
GB0710844D0
(en)
|
2007-06-06 |
2007-07-18 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
|
DE102007034620A1
(de)
|
2007-07-25 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue B1-Antagonisten
|
|
WO2009026248A2
(en)
|
2007-08-17 |
2009-02-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
|
|
EP2222646B1
(en)
|
2007-09-17 |
2014-01-22 |
AbbVie Bahamas Ltd. |
Uracil or thymine derivative for treating hepatitis c
|
|
US20090076275A1
(en)
|
2007-09-19 |
2009-03-19 |
David Robert Bolin |
Diacylglycerol acyltransferase inhibitors
|
|
US20100210655A1
(en)
|
2007-10-11 |
2010-08-19 |
Yun Ding |
NOVEL sEH INHIBITORS AND THEIR USE
|
|
CA2702950A1
(en)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Methods and compounds for modulating cannabinoid activity
|
|
CA2702699A1
(en)
|
2007-10-18 |
2009-04-23 |
Novartis Ag |
Csf-1r inhibitors compositions, and mthods of use
|
|
CN101874019B
(zh)
|
2007-11-29 |
2013-06-12 |
弗·哈夫曼-拉罗切有限公司 |
制备异吲哚衍生物的方法以及制备它们的中间体的方法
|
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
|
ATE531711T1
(de)
*
|
2007-12-18 |
2011-11-15 |
Arena Pharm Inc |
Für die behandlung von autoimmunerkrankungen und entzündlichen erkrankungen geeignete tetrahydrocyclopentaäbüindol-3- ylcarbonsäurederivate
|
|
EP2078711A1
(en)
|
2007-12-28 |
2009-07-15 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. |
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
|
|
GB0800035D0
(en)
*
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
CN101225070B
(zh)
|
2008-01-31 |
2010-04-14 |
上海交通大学 |
用于抗肿瘤的药物
|
|
SI2242740T1
(sl)
|
2008-02-05 |
2013-03-29 |
Sanofi |
SF5-derivati kot PAR1 inhibitorji, njihova priprava in uporaba kot zdravila
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
GB0804702D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
GB0809776D0
(en)
|
2008-05-29 |
2008-07-09 |
Amura Therapeutics Ltd |
Compounds
|
|
CA2727252A1
(en)
|
2008-07-01 |
2010-01-07 |
Genentech, Inc. |
Isoindolone derivatives as mek kinase inhibitors and methods of use
|
|
ES2612731T3
(es)
|
2008-08-19 |
2017-05-18 |
Janssen Pharmaceutica Nv |
Antagonistas de receptores al frío de mentol
|
|
JPWO2010024258A1
(ja)
|
2008-08-29 |
2012-01-26 |
塩野義製薬株式会社 |
Ｐｉ３ｋ阻害活性を有する縮環アゾール誘導体
|
|
CA2741400A1
(en)
|
2008-09-16 |
2010-03-25 |
Merck & Co., Inc. |
Sulfonamide derivative metabotropic glutamate r4 ligands
|
|
US20100125081A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 574
|
|
US20100125087A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 575
|
|
CN101455661B
(zh)
|
2008-11-19 |
2012-10-10 |
中国科学院上海有机化学研究所 |
3-取代苯酞及其类似物的用途
|
|
WO2010077680A2
(en)
|
2008-12-08 |
2010-07-08 |
Vm Discovery Inc. |
Compositions of protein receptor tyrosine kinase inhibitors
|
|
WO2010086311A1
(en)
|
2009-01-28 |
2010-08-05 |
Bayer Cropscience Ag |
Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
|
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
|
WO2011078984A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Sanofi |
[4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
|
|
WO2011090473A1
(en)
|
2010-01-19 |
2011-07-28 |
Frank Ivy Carroll |
Kappa opioid receptor binding ligands
|
|
SG182662A1
(en)
|
2010-01-28 |
2012-08-30 |
Harvard College |
Compositions and methods for enhancing proteasome activity
|
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
EP2571876B1
(en)
|
2010-05-21 |
2016-09-07 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
|
WO2012028100A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
WO2012027965A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
IN2013CN02463A
(enExample)
|
2010-09-03 |
2015-08-07 |
Forma Tm Llc |
|
|
WO2012041814A1
(en)
|
2010-09-27 |
2012-04-05 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
JP2013253019A
(ja)
|
2010-09-28 |
2013-12-19 |
Kowa Co |
新規なピペリジン誘導体及びこれを含有する医薬
|
|
AU2011326071A1
(en)
|
2010-11-08 |
2013-05-23 |
Lycera Corporation |
N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of RORy activity and the treatment of diseases
|
|
AU2011328520A1
(en)
|
2010-11-10 |
2013-05-02 |
Grunenthal Gmbh |
Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
|
|
WO2012100734A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Compounds useful as retinoid-related orphan receptor gamma modulators
|
|
WO2012100732A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
CN102180780A
(zh)
|
2011-03-07 |
2011-09-14 |
中国科学技术大学 |
茚酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途
|
|
CA2829123C
(en)
|
2011-03-14 |
2016-04-12 |
Eternity Bioscience Inc. |
Quinazolinediones and their use
|
|
UY33966A
(es)
|
2011-03-25 |
2012-10-31 |
Abbott Lab |
Antagonistas del receptor transitorio potencial de vanilloides 1 (trpv1)
|
|
JP5996628B2
(ja)
|
2011-04-04 |
2016-09-21 |
メルク パテント ゲーエムベーハー |
金属錯体
|
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
JP5902029B2
(ja)
|
2011-04-28 |
2016-04-13 |
日本たばこ産業株式会社 |
アミド化合物およびその医薬用途
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
EP2747560A4
(en)
|
2011-07-29 |
2015-02-25 |
Tempero Pharmaceuticals Inc |
CONNECTIONS AND METHODS
|
|
WO2013019682A1
(en)
*
|
2011-07-29 |
2013-02-07 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
WO2013019653A1
(en)
|
2011-07-29 |
2013-02-07 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
US20140155419A1
(en)
|
2011-07-29 |
2014-06-05 |
Erkan Baloglu |
Compounds and methods
|
|
US9156837B2
(en)
|
2011-07-29 |
2015-10-13 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2013029338A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel compounds
|
|
EP2759533B1
(en)
|
2011-09-22 |
2017-08-02 |
Takeda Pharmaceutical Company Limited |
Condensed heterocyclic compound
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
|
WO2013067036A1
(en)
|
2011-10-31 |
2013-05-10 |
Rutgers, The State University Of New Jersey |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
|
US20140249196A1
(en)
*
|
2011-11-22 |
2014-09-04 |
Theodore Mark Kamenecka |
N-benzylbenzimidazole modulators of pparg
|
|
WO2013078240A1
(en)
*
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-biphenylmethylbenzimidazole modulators of pparg
|
|
US9815851B2
(en)
|
2011-12-02 |
2017-11-14 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
US8741892B2
(en)
|
2011-12-05 |
2014-06-03 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
US8642774B2
(en)
|
2011-12-08 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
US8796467B2
(en)
|
2011-12-13 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
WO2013092460A1
(en)
|
2011-12-20 |
2013-06-27 |
Syngenta Participations Ag |
Cyclic bisoxime microbicides
|
|
CA2860382C
(en)
|
2011-12-21 |
2017-09-12 |
Allergan, Inc. |
Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
|
|
US9216988B2
(en)
|
2011-12-22 |
2015-12-22 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as RORc modulators
|
|
US20130190356A1
(en)
|
2011-12-22 |
2013-07-25 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as rorc modulators
|
|
WO2013100027A1
(ja)
|
2011-12-28 |
2013-07-04 |
武田薬品工業株式会社 |
複素環化合物
|
|
EP2844247A4
(en)
|
2012-04-20 |
2015-11-25 |
Anderson Gaweco |
ROR MODULATORS AND ITS USES
|
|
MX2014012989A
(es)
|
2012-04-27 |
2015-01-22 |
Glaxo Group Ltd |
Compuestos novedosos.
|
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
|
US9708268B2
(en)
|
2012-04-30 |
2017-07-18 |
Innov17 Llc |
ROR modulators and their uses
|
|
US9394315B2
(en)
|
2012-05-08 |
2016-07-19 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
|
|
MX367341B
(es)
|
2012-05-08 |
2019-08-14 |
Merck Sharp & Dohme |
Tetrahidronaftiridina y compuestos biciclicos relacionados para la inhibicion de la actividad de rorgamma y el tratamiento de enfermedades.
|
|
US9266827B2
(en)
|
2012-05-08 |
2016-02-23 |
Merck Sharp & Dohme Corp. |
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
|
|
WO2013178362A1
(en)
|
2012-05-31 |
2013-12-05 |
Phenex Pharmaceuticals Ag |
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma]
|
|
TW201414704A
(zh)
|
2012-07-02 |
2014-04-16 |
Biogen Idec Inc |
作爲ＲＯＲ－γ受體之反向促效劑之含聯芳化合物
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
|
KR20150058284A
(ko)
|
2012-09-21 |
2015-05-28 |
사노피 |
Apj 수용체 조절자로서의 벤조이미다졸-카르복시산 아미드 유도체
|
|
ES2628365T3
(es)
*
|
2012-10-16 |
2017-08-02 |
Janssen Pharmaceutica N.V. |
Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
|
|
US10035790B2
(en)
|
2012-10-19 |
2018-07-31 |
Exelixis, Inc. |
RORγ modulators
|
|
PE20151144A1
(es)
|
2012-12-06 |
2015-08-02 |
Glaxo Group Ltd |
Moduladores de la orphan receptor gamma retinoides relacionados (ror - gamma) para uso en el tratamiento de las enfermedades autoinmunes e inflamatorias
|
|
WO2013171729A2
(en)
|
2013-01-08 |
2013-11-21 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl amide compounds as rorgamat modulator
|
|
EP2991994B1
(en)
|
2013-05-01 |
2018-08-15 |
Vitae Pharmaceuticals, Inc. |
Thiazolopyrrolidine inhibitors of ror-gamma
|
|
TWI652014B
(zh)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
雜環取代之雙環唑殺蟲劑
|
|
EP3057950B1
(en)
*
|
2013-10-15 |
2020-12-02 |
Janssen Pharmaceutica NV |
Phenyl linked quinolinyl modulators of ror-gamma-t
|
|
WO2015083130A1
(en)
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
|
EA030907B1
(ru)
|
2013-12-24 |
2018-10-31 |
Президент Энд Феллоус Оф Гарвард Колледж |
Аналоги кортистатина, их синтез и применения
|
|
JP2015124178A
(ja)
|
2013-12-26 |
2015-07-06 |
東レ株式会社 |
環状アミン誘導体及びその医薬用途
|
|
WO2015101928A1
(en)
|
2013-12-31 |
2015-07-09 |
Aurigene Discovery Technologies Limited |
Fused thiophene and thiazole derivatives as ror gamma modulators
|
|
ES2734700T3
(es)
|
2014-02-03 |
2019-12-11 |
Basf Se |
Compuestos de ciclopenteno y ciclopentadieno para controlar pestes invertebradas
|
|
EA031804B1
(ru)
|
2014-02-03 |
2019-02-28 |
Вайтаи Фармасьютиклз, Инк. |
Дигидропирролопиридиновые ингибиторы ror-гамма
|
|
CN104926733B
(zh)
*
|
2014-03-18 |
2019-05-10 |
北京韩美药品有限公司 |
作为RORγ调节剂的化合物
|
|
EA037928B1
(ru)
|
2014-03-26 |
2021-06-08 |
Ф. Хоффманн-Ля Рош Аг |
Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
PE20161223A1
(es)
|
2014-03-26 |
2016-11-12 |
Hoffmann La Roche |
Compuestos condensados de [1,4]diazepina como inhibidores de la produccion de autotaxina (atx) y acido lisofosfatidico (lpa)
|
|
EA201691913A1
(ru)
|
2014-03-26 |
2017-02-28 |
Басф Се |
Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
|
|
CA2942871A1
(en)
*
|
2014-03-27 |
2015-10-01 |
Piramal Enterprises Limited |
Ror-gamma modulators and uses thereof
|
|
SG11201607518RA
(en)
*
|
2014-04-16 |
2016-10-28 |
Glenmark Pharmaceuticals Sa |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
|
SI3207043T1
(sl)
|
2014-10-14 |
2019-04-30 |
Vitae Pharmaceuticals, Inc. |
Dihidropirolopiridinovi inhibitorji za ROR-gama
|
|
CA2965336A1
(en)
|
2014-10-22 |
2016-04-28 |
The Board Of Regents Of The University Of Texas System |
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
|
|
US9845308B2
(en)
|
2014-11-05 |
2017-12-19 |
Vitae Pharmaceuticals, Inc. |
Isoindoline inhibitors of ROR-gamma
|
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
CN112679467B
(zh)
|
2015-03-11 |
2024-11-01 |
Fmc公司 |
杂环取代的二环唑杀有害生物剂
|
|
WO2017024018A1
(en)
|
2015-08-05 |
2017-02-09 |
Vitae Pharmaceuticals, Inc. |
Modulators of ror-gamma
|
|
CN108463458B
(zh)
|
2015-11-20 |
2022-02-01 |
生命医药有限责任公司 |
ROR-γ的调节剂
|
|
TW202220968A
(zh)
|
2016-01-29 |
2022-06-01 |
美商維它藥物有限責任公司 |
ＲＯＲ－γ調節劑
|
|
US9481674B1
(en)
|
2016-06-10 |
2016-11-01 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|